Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper.

Fecha de publicación: 19/07/2022 Fecha Ahead of Print: 20/07/2022

Autores de IIS La Fe

Marina Berenguer Haym

Autor

Participantes ajenos a IIS La Fe

Marjot, Thomas
Eberhardt, Christiane S.
Boettler, Tobias
Belli, Luca S.
Buti, Maria
Jalan, Rajiv
Mondelli, Mario U.
Moreau, Richard
Shouval, Daniel
Berg, Thomas
Cornberg, Markus

Grupos

Hepatología, Cirugia Hepatobiliopancreática y Trasplantes

Abstract

The COVID-19 pandemic has presented a serious challenge to the hepatology community, particularly healthcare professionals and patients. While the rapid development of safe and effective vaccines and treatments has improved the clinical landscape, the emergence of the omicron variant has presented new challenges. Thus, it is timely that the European Association for the Study of the Liver provides a summary of the latest data on the impact of COVID-19 on the liver and issues guidance on the care of patients with chronic liver disease, hepatobiliary cancer, and previous liver transplantation, as the world continues to deal with the consequences of the COVID-19 pandemic.

Datos de la publicación

ISSN/ISSNe:: 0168-8278, 1600-0641
Tipo:: Article
Páginas:: 1161-1197
DOI:: 10.1016/j.jhep.2022.07.008
PubMed:: 35868584
Factor de Impacto:: 7,351 SCImago ℠
Cuartil:: Q1 SCImago ℠

Documentos

No hay documentos

Métricas

Filiaciones

Marjot, Thomas:: Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Oxford Liver Unit, Oxford, England

Univ Oxford, Nuffield Dept Med, Translat Gastroenterol Unit, Oxford, England
Eberhardt, Christiane S.:: Univ Geneva, Ctr Vaccinol & Neonatal Immunol, Dept Pathol & Immunol, Geneva, Switzerland

Univ Geneva, Geneva Univ Hosp, Fac Med, Ctr Vaccinol,Div Gen Pediat,Dept Woman Child & Ad, Geneva, Switzerland
Boettler, Tobias:: Univ Freiburg, Dept Med 2, Fac Med, Med Ctr, Freiburg, Germany
Belli, Luca S.:: GOM Niguarda, Dept Hepatol & Gastroenterol, Milan, Italy
Berenguer, Marina:: Instituto de Investigación. IISLaFe, Liver Transplantat & Hepatol Unit & Ciberehd, Valencia, Spain

Instituto de Investigación. Hosp Univ & Politecn La Fe, Valencia, Spain

Univ Valencia, Dept Med, Valencia, Spain
Buti, Maria:: Hosp Univ Valle Hebron, Liver Unit, Barcelona, Spain

Inst Carlos II, CIBEREHD, Dept Med 2, Div Hepatol, Barcelona, Spain
Jalan, Rajiv:: UCL, Liver Failure Grp, Inst Liver & Digest Hlth, Royal Free Campus, London, England

European Fdn Study Chron Liver Failure, Barcelona, Spain
Mondelli, Mario U.:: Univ Pavia, Fdn IRCCS Policlin San Matteo, Div Clin Immunol & Infect Dis, Hannover, Germany

German Ctr Infect Res DZ, Dept Internal Med & Therapeut, Partner Site Hannover Braunschweig, Hannover, Germany
Moreau, Richard:: Hop Beaujon, AP HP, Serv Hepatol, Clichy, France

European Fdn Study Chron Liver Failure, Barcelona, Spain

INSERM, Ctr Rech Inflammat, Paris, France

Univ Paris Cite, Paris, France
Shouval, Daniel:: Liver Unit, Hadassah-Hebrew University Hospital, Jerusalem, Israel
Berg, Thomas:: Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany
Cornberg, Markus:: Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH), Hannover, Germany

Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH), Hannover, Germany

German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Germany

Keywords

COVID-19; SARS-CoV-2; chronic liver disease; cirrhosis; hepatobiliary cancer; liver transplantation; vaccination

Campos de Estudio

Cita

Cita Bibliográfica